Futures Mixed as Iran War Tensions Dominate Pre-Market Trading

U.S. stock futures are trading mixed in pre-market hours as escalating tensions from the Iran war continue to create uncertainty across global markets, with geopolitical headlines dominating overnight trading sessions.

Overnight Market Developments

The previous session saw broad-based gains across major indices, with the S&P 500 (SPY) closing at $658.93, up 0.47%, while the Nasdaq 100 (QQQ) advanced 0.60% to $588.50. The Dow Jones (DIA) posted a more modest 0.37% gain to $466.77. However, overnight futures are showing mixed signals as investors digest the latest developments from the Iran conflict.

Multiple reports indicate the conflict is expanding beyond military operations, with Russia reportedly providing cyber support and spy imagery to Iran, according to Ukrainian sources. The Israeli military has issued warnings for Iranian civilians to avoid using trains, suggesting potential infrastructure targeting.

Global Economic Impact

The Iran war is creating ripple effects across global markets and economies. India is reportedly planning sovereign guarantees on loans to businesses affected by the conflict, while Bulgaria’s central bank suggests the crisis may boost euro adoption. Real estate markets are also feeling pressure, with agents reporting disruptions to the spring housing market.

Energy markets remain a key focus as the conflict threatens regional oil infrastructure and supply chains. The situation has prompted warnings about potential impacts on U.S. global leadership, according to Italian officials.

Sector Performance to Watch

Monday’s session showed defensive rotation with Consumer Staples leading gains at 0.94%, followed by Consumer Discretionary (+0.82%) and Energy (+0.73%). Technology stocks advanced 0.58% despite geopolitical headwinds. Healthcare (-0.36%), Materials (-0.38%), and Utilities (-0.37%) posted declines, reflecting risk-off sentiment in certain sectors.

Earnings in Focus

Several companies report earnings today, including Aehr Test Systems (AEHR) with an estimated loss of $0.07 per share on revenue of $11.1 million, and Pacific Biosciences (PACB) expected to post a $0.14 loss per share on $40.8 million in revenue. Nexxt Solutions (NXXT) and Krusoe (KRUS) are also scheduled to report results.

Market Volatility Factors

Viridian Therapeutics (VRDN) was among notable losers in the previous session, declining 26.22% to $13.90. The sharp move highlights continued volatility in individual names amid broader market uncertainty.

Trump’s ceasefire deadline looms as Iran remains defiant under ongoing airstrikes, adding to market tension. The conflict’s duration and scope remain key variables for market direction.

This article is generated from market data for informational purposes only. It does not constitute investment advice.